Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of chlorthalidone and hydrochlorothiazide for treatment of systemic hypertension
TCTR20191006002Phase 4Not yet recruiting
- Sponsor
- Berlin Pharmaceutical
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone, hydrochlorothiazide in systemic hypertension, sponsored by Berlin Pharmaceutical. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
chlorthalidonehydrochlorothiazide
03
Conditions
systemic hypertension
Beyond the preview
Go deeper on TCTR20191006002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191006002.